Semaglutide GLP-1 is an injectable weight loss medication approved by the FDA
heartburn, acid regurgitation, belching, bloating, abdominal distension, chest pain, postprandial fullness, early satiety, and flatulence
L- :
Published clinical trial data from the SURMOUNT trials has shown pronounced average effects on body weight in some trial populations

Paige Robinson MS, RD, LD Licensed in IL & TX Hannah Eddy MDA, RD, LD Licensed in TX Megan Bolyard MS, RD, LD Licensed in IL, TX, & NC Anisah Ahmed MS, RD, LD Licensed in TX Audrey McKinney MS, RD, LD Licensed in TX Summer Spaide RD, LD Licensed in TX Alyssa Moore MS, RD, LD Licensed in TX Alisha Macas MS, RD, LD Licensed in IL & TX Business Development RDII Cassidy Storts RD, LD Licensed in TX Brittany Thiel RD, LD Licensed in TX & PA Kacilyn Helton MCN, RD, LD Licensed in TX Business Development Manager Bryan Johnson MS, RD, LD Licensed in TX Senior Dietitian Anne-Marie Alford MS, RD, LD Licensed in TX Clinical Manager Remy Luper RD, LD Licensed in TX Clinical Manager Common GLP-1 Symptoms Addressed in Nutrition Counseling Our dietitians offer ongoing guidance and support throughout your GLP-1 journey, so you know which symptoms are normal and which should be addressed with your medical provider
BMJ Open, 7 (8), e016224